These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 32151365)

  • 1. [Gastrointestinal neuroendocrine tumors: update 2024].
    Lahner H; Pavel M
    Inn Med (Heidelb); 2024 Jul; 65(7):664-671. PubMed ID: 38900278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new era for the systemic therapy of neuroendocrine tumors.
    Eads JR; Meropol NJ
    Oncologist; 2012; 17(3):326-38. PubMed ID: 22357730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second Primary Neuroendocrine Tumors: A Case Series.
    Emengo PO; Kim MK; Divino CM
    Pancreas; 2024 May; 53(5):e467-e469. PubMed ID: 38728214
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha-emitter therapy for pediatric relapsed metastatic pancreatic neuroendocrine tumor.
    Wahba A; Delpassand ES; Nunez R; Esfandiari R; Venkatramani R
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30961. PubMed ID: 38556730
    [No Abstract]   [Full Text] [Related]  

  • 5. ESMO Gastrointestinal Cancers Congress 2024.
    Gourd K
    Lancet Oncol; 2024 Aug; 25(8):961. PubMed ID: 38972325
    [No Abstract]   [Full Text] [Related]  

  • 6. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.
    Kulke MH; Anthony LB; Bushnell DL; de Herder WW; Goldsmith SJ; Klimstra DS; Marx SJ; Pasieka JL; Pommier RF; Yao JC; Jensen RT;
    Pancreas; 2010 Aug; 39(6):735-52. PubMed ID: 20664472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Oberg K; Jelic S;
    Ann Oncol; 2008 May; 19 Suppl 2():ii104-5. PubMed ID: 18456741
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroendocrine tumours: clinical presentation and management of localized disease.
    Kulke MH
    Cancer Treat Rev; 2003 Oct; 29(5):363-70. PubMed ID: 12972355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroenteropancreatic neuroendocrine tumors. Where are we now?
    Castellano D
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():1. PubMed ID: 21365184
    [No Abstract]   [Full Text] [Related]  

  • 10. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
    Sorbye H; Baudin E; Perren A
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Gastrointestinal and Pancreatic Neuroendocrine Tumors.
    Pawlik TM
    Surg Oncol Clin N Am; 2020 Apr; 29(2):xiii-xiv. PubMed ID: 32151365
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.